EdgarLookup

SECURITY NATIONAL FINANCIAL CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that SECURITY NATIONAL FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
9.3%
Profit Margin
Net income ÷ revenue
2.1%
Return on Assets
Net income ÷ assets
2.81x
Debt-to-Equity
Total liabilities ÷ equity
+3%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $344.59M Mar 16, 2026
FY2025 Dec 31, 2024 $334.52M Mar 16, 2026
FY2024 Dec 31, 2023 $318.50M Mar 31, 2025
FY2023 Dec 31, 2022 $389.65M Mar 29, 2024
FY2022 Dec 31, 2021 $470.70M Mar 31, 2023
FY2021 Dec 31, 2020 $481.46M Mar 31, 2022
FY2019 Dec 31, 2019 $77.74M Mar 30, 2020
FY2019 Sep 30, 2019 $75.38M Mar 30, 2020
FY2019 Jun 30, 2019 $68.45M Mar 30, 2020
FY2019 Mar 31, 2019 $61.49M Mar 30, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $32.15M Mar 16, 2026
FY2025 Dec 31, 2024 $29.12M Mar 16, 2026
FY2024 Dec 31, 2023 $14.50M Mar 31, 2025
FY2023 Dec 31, 2022 $25.69M Mar 29, 2024
FY2022 Dec 31, 2021 $39.52M Mar 31, 2023
FY2021 Dec 31, 2020 $55.60M Mar 31, 2022
FY2020 Dec 31, 2019 $10.89M Mar 31, 2021
FY2019 Dec 31, 2018 $21.69M Mar 30, 2020
FY2018 Dec 31, 2017 $14.11M Mar 29, 2019
FY2017 Dec 31, 2016 $12.19M Apr 2, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $45.54M Mar 16, 2026
FY2025 Dec 31, 2024 $57.32M Mar 16, 2026
FY2024 Dec 31, 2023 $53.88M Mar 31, 2025
FY2023 Dec 31, 2022 $130.45M Mar 29, 2024
FY2022 Dec 31, 2021 $144.64M Mar 31, 2023
FY2021 Dec 31, 2020 ($129.63M) Mar 31, 2022
FY2020 Dec 31, 2019 ($75.60M) Mar 31, 2021
FY2017 Dec 31, 2017 $44.32M Apr 2, 2018
FY2017 Dec 31, 2016 $35.54M Apr 2, 2018
FY2016 Dec 31, 2015 ($28.11M) Aug 25, 2017

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.69M Mar 16, 2026
FY2025 Dec 31, 2024 $2.47M Mar 16, 2026
FY2024 Dec 31, 2023 $1.11M Mar 31, 2025
FY2023 Dec 31, 2022 $1.60M Mar 29, 2024
FY2022 Dec 31, 2021 $5.22M Mar 31, 2023
FY2021 Dec 31, 2020 $1.63M Mar 31, 2022
FY2020 Dec 31, 2019 $1.84M Mar 31, 2021
FY2019 Dec 31, 2018 $1.28M Mar 30, 2020
FY2018 Dec 31, 2017 ($911.0K) Mar 29, 2019
FY2017 Dec 31, 2016 $3.57M Apr 2, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.56B Mar 16, 2026
FY2025 Dec 31, 2024 $1.49B Mar 16, 2026
FY2024 Dec 31, 2023 $1.43B Mar 31, 2025
FY2023 Dec 31, 2022 $1.46B Mar 29, 2024
FY2022 Dec 31, 2021 $1.55B Mar 31, 2023
FY2021 Dec 31, 2020 $1.55B Mar 31, 2022
FY2020 Dec 31, 2019 $1.33B Mar 31, 2021
FY2019 Dec 31, 2018 $1.05B Mar 30, 2020
FY2018 Dec 31, 2017 $982.17M Mar 29, 2019
FY2017 Dec 31, 2016 $952.42M Apr 2, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.15B Mar 16, 2026
FY2025 Dec 31, 2024 $1.11B Mar 16, 2026
FY2024 Dec 31, 2023 $1.12B Mar 31, 2025
FY2023 Dec 31, 2022 $1.17B Mar 29, 2024
FY2022 Dec 31, 2021 $1.25B Mar 31, 2023
FY2021 Dec 31, 2020 $1.28B Mar 31, 2022
FY2020 Dec 31, 2019 $1.14B Mar 31, 2021
FY2019 Dec 31, 2018 $879.00M Mar 30, 2020
FY2018 Dec 31, 2017 $833.61M Mar 29, 2019
FY2017 Dec 31, 2016 $819.86M Apr 2, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $410.37M Mar 16, 2026
FY2025 Dec 31, 2024 $381.90M Mar 16, 2026
FY2025 Dec 31, 2023 $312.90M Mar 16, 2026
FY2024 Dec 31, 2022 $292.79M Mar 31, 2025
FY2023 Dec 31, 2021 $299.77M Mar 29, 2024
FY2022 Dec 31, 2020 $263.99M Mar 31, 2023
FY2021 Dec 31, 2019 $196.71M Mar 31, 2022
FY2020 Dec 31, 2018 $171.81M Mar 31, 2021
FY2019 Dec 31, 2017 $148.57M Mar 30, 2020
FY2018 Dec 31, 2016 $132.56M Mar 29, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.25M Mar 16, 2026
FY2025 Dec 31, 2024 $5.25M Mar 16, 2026
FY2024 Dec 31, 2023 $5.25M Mar 31, 2025
FY2025 Dec 31, 2022 $5.25M Mar 16, 2026
FY2023 Dec 31, 2021 $5.25M Mar 29, 2024
FY2022 Dec 31, 2020 $3.52M Mar 31, 2023
FY2021 Dec 31, 2019 $3.52M Mar 31, 2022
FY2020 Dec 31, 2018 $2.77M Mar 31, 2021
FY2019 Dec 31, 2017 $2.77M Mar 30, 2020
FY2017 Dec 31, 2016 $2.77M Apr 2, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $248.80M Mar 16, 2026
FY2025 Dec 31, 2024 $227.80M Mar 16, 2026
FY2024 Dec 31, 2023 $206.98M Mar 31, 2025
FY2023 Dec 31, 2022 $202.16M Mar 29, 2024
FY2022 Dec 31, 2021 $184.54M Mar 31, 2023
FY2021 Dec 31, 2020 $153.74M Mar 31, 2022
FY2020 Dec 31, 2019 $101.26M Mar 31, 2021
FY2019 Dec 31, 2018 $95.20M Mar 30, 2020
FY2018 Dec 31, 2017 $77.52M Mar 29, 2019
FY2017 Dec 31, 2016 $67.41M Apr 2, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $102.26M Mar 16, 2026
FY2025 Dec 31, 2024 $140.55M Mar 16, 2026
FY2024 Dec 31, 2023 $126.94M Mar 31, 2025
FY2023 Dec 31, 2022 $120.92M Mar 29, 2024
FY2022 Dec 31, 2021 $131.35M Mar 31, 2023
FY2021 Dec 31, 2020 $106.22M Mar 31, 2022
FY2020 Dec 31, 2019 $127.75M Mar 31, 2021
FY2019 Dec 31, 2018 $142.20M Mar 30, 2020
FY2018 Dec 31, 2017 $45.32M Mar 29, 2019
FY2017 Dec 31, 2016 $38.99M Apr 2, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2021 Dec 31, 2021 $280.33M Mar 31, 2022
FY2020 Dec 31, 2020 $253.77M Mar 31, 2021

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Mar 16, 2026
FY2025 Dec 31, 2024 1 Mar 16, 2026
FY2024 Dec 31, 2023 0 Mar 31, 2025
FY2023 Dec 31, 2022 1 Mar 29, 2024
FY2022 Dec 31, 2021 1 Mar 31, 2023
FY2021 Dec 31, 2020 2 Mar 31, 2022
FY2019 Dec 31, 2019 0 Mar 30, 2020
FY2019 Sep 30, 2019 0 Mar 30, 2020
FY2019 Jun 30, 2019 0 Mar 30, 2020
FY2019 Mar 31, 2019 0 Mar 30, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Mar 16, 2026
FY2025 Dec 31, 2024 1 Mar 16, 2026
FY2024 Dec 31, 2023 0 Mar 31, 2025
FY2023 Dec 31, 2022 1 Mar 29, 2024
FY2022 Dec 31, 2021 1 Mar 31, 2023
FY2021 Dec 31, 2020 2 Mar 31, 2022
FY2019 Dec 31, 2019 0 Mar 30, 2020
FY2019 Sep 30, 2019 0 Mar 30, 2020
FY2019 Jun 30, 2019 0 Mar 30, 2020
FY2019 Mar 31, 2019 0 Mar 30, 2020